Machine Learning

As BioPharma races to adopt AI, fragmented data remains a huge hurdle. A Boston forum aims to find solutions for building a trusted digital foundation.

For the 8th straight year, Equashield dominates the CSTD market. We explore the tech, trust, and automation driving its success in protecting workers.

A new partnership between yieldWerx and WATS promises to unify fragmented manufacturing data, revolutionizing quality control for complex electronics.

Butterfly Network adds B. Braun veteran Caroll Neubauer to its board, a strategic move to leverage his global scaling and policy expertise for growth.

By acquiring Sphere's proven methodology, Startup Science aims to give every founder the structured guidance once reserved for elite accelerator programs.

Dr. Amanda Wilson's appointment to a powerful D.C. council puts her tech-driven addiction treatment model in the national policy spotlight.

With two pivotal trial readouts looming and cash projected to last only into Q4, Tvardi Therapeutics faces a make-or-break year for its STAT3 inhibitors.

Travel tech giant Amadeus navigates geopolitical turbulence with solid Q1 growth, while a major acquisition signals a bold future for frictionless travel.

How one company turned its internal training program into a strategic powerhouse, earning a top award and creating a blueprint for the future of work.

At a top Paris expo, GUYU's biotech arm BioQ unveiled cellular anti-aging ingredients, signaling a new era of Chinese innovation in the beauty supply chain.

An innovative RNA-editing therapy for hepatocellular carcinoma has received a major FDA designation, potentially accelerating its path to patients.

A new fund, NICO, challenges ESG norms by investing in tobacco giants, aiming to force a shift to safer products. Can engagement succeed where exclusion has failed?

SimScale has launched Engineering AI agents that automate entire simulation workflows, promising to eliminate bottlenecks and slash design cycles from months to hours.

A three-month FDA delay for a new LEQEMBI injection highlights the high-stakes race for a convenient Alzheimer's therapy and its complex safety hurdles.

A KIST-led delegation of Korean quantum startups partners with IBM, signaling a major push to commercialize deep tech on the global stage.

A Swedish startup is launching a 'participation-first' video app in Brazil, betting that users are tired of passive scrolling. Can it succeed?

Faraday Future and a new business school are launching an ambitious robotics institute, but can they deliver on the promise to standardize the future of AI?

A new, free AI platform, MattsonIQ™, promises to democratize expert food intelligence, but what does it mean for the future of R&D and market competition?

The chipmaker topped Q1 estimates and eyes a strong Q2, fueled by EV and AI markets, even as restructuring charges weigh on its bottom line.

With a strong balance sheet and promising data, Enliven Therapeutics is pushing its lead leukemia drug, ELVN-001, into a pivotal late-stage trial.